FDA Drug Information Updates

Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.

150

LikeLikedUnlike

Episodes 31-45 of 47

Drug Safety Communications
FDA Drug Information Updates
Drug Safety Communications
Patents and Exclusivity
FDA Drug Information Updates
Patents and Exclusivity
Medication Errors
FDA Drug Information Updates
Medication Errors
Medication Guides
FDA Drug Information Updates
Medication Guides
Communicating Drug Safety Messages
FDA Drug Information Updates
Communicating Drug Safety Messages
Alyson Saben on the Eyes, Ears, and Muscle Behind FDA's Efforts to Protect Public Health.
FDA Drug Information Updates
Alyson Saben on the Eyes, Ears, and Muscle Behind FDA's Efforts to Protect Public Health.
Drug Promotion
FDA Drug Information Updates
Drug Promotion
The Electronic Orange Book
FDA Drug Information Updates
The Electronic Orange Book
Dr. Dianne Murphy on Effective and Proper Uses of Medicines and Devices in Children
FDA Drug Information Updates
Dr. Dianne Murphy on Effective and Proper Uses of Medicines and Devices in Children
Drug Name Review
FDA Drug Information Updates
Drug Name Review
Tim Coté on Orphan Drugs and the Fight Against Rare Diseases
FDA Drug Information Updates
Tim Coté on Orphan Drugs and the Fight Against Rare Diseases
John Jenkins on Changes in the Way New Drugs are Evaluated.
FDA Drug Information Updates
John Jenkins on Changes in the Way New Drugs are Evaluated.
Managing Drug Shortages
FDA Drug Information Updates
Managing Drug Shortages
Communicating Benefit and Risk Information
FDA Drug Information Updates
Communicating Benefit and Risk Information
New Safe Use Requirements for Long-Acting Beta-Agonists (LABAs)
FDA Drug Information Updates
New Safe Use Requirements for Long-Acting Beta-Agonists (LABAs)